I think the only thing preventing us from being in a range of $1 to $3 pps after cream sales start WOULD BE TRANSPERENCY. I say that because transparency does lack within the company at times because the scientists and Dr.s are not speaking in a language us common investors can understand. Although there telling the truth, we may want more or interpret things differently. With the addition of our CFO, and most recent addition, I expect that to change.

Expect transparency in a language we understand moving forward that will help prop up this stock price.

We should have one or two more management positions to solidify this team that has worked for Nasdaq companies.

Investors like transparency and security, and this group should start delivering that I believe.